Integer Holdings Co. (NYSE:ITGR) Shares Acquired by Northern Trust Corp

Northern Trust Corp boosted its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 14.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 422,380 shares of the medical equipment provider's stock after purchasing an additional 52,556 shares during the period. Northern Trust Corp owned about 1.26% of Integer worth $55,974,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Mather Group LLC. raised its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Integer in the fourth quarter worth $27,000. R Squared Ltd purchased a new stake in shares of Integer in the fourth quarter valued at $44,000. Sterling Capital Management LLC boosted its stake in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 279 shares during the last quarter. Finally, Principal Securities Inc. increased its position in Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after purchasing an additional 152 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Stock Up 0.6 %

ITGR opened at $118.96 on Thursday. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The firm has a 50 day moving average price of $118.45 and a 200 day moving average price of $129.83. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The company has a market cap of $4.15 billion, a PE ratio of 35.40, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. During the same quarter last year, the firm posted $1.14 EPS. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. Sell-side analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insider Transactions at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.16% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ITGR. StockNews.com cut shares of Integer from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. KeyCorp decreased their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Raymond James lifted their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, April 25th. Finally, Benchmark reduced their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.